- ProKidney press release (NASDAQ:PROK): FY GAAP EPS of -$0.57 beats by $0.08.
- Cash, cash equivalents and marketable securities as of December 31, 2023, totaled $363.0 million, compared to $490.3 million on December 31, 2022.
- We expect that our existing cash, cash equivalents and marketable securities held at December 31, 2023, will enable us to fund our operating expenses and capital expenditure requirements into the fourth quarter of 2025.
ProKidney GAAP EPS of -$0.57 beats by $0.08
Recommended For You
More Trending News
About PROK Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| PROK | - | - |
| ProKidney Corp. | ||